Subungual melanoma - what you need to know about it. A literature review
DOI:
https://doi.org/10.12775/JEHS.2024.73.51811Keywords
melanoma, subungual melanoma, melanocytic lesion, dermoscopyAbstract
Introduction and objective:
Melanoma is one of the most malignant skin cancers originating from pigment cells, accounting for 5–7% of all skin cancers. The prognosis, especially in case of late diagnosis, is poor. The aim of the study is to systematise information on subungual melanoma. To raise awareness among the public and professionals working in the skin care sector of the diagnosis, early detection and treatment of subungual melanoma.
Brief description of the state of knowledge:
Subungual melanoma originates from subungual melanoma lentigines and constitutes from 0.7% to 3.5% of all malignant melanomas. Among dark-skinned populations, this subtype accounts for up to 30% and is the most common subtype of malignant melanoma among African Americans, Asians, and Latinos. Subungual melanoma occurs asymmetrically, most often affecting the big toe or thumb. In this disease, the starting point are melanocytes, which undergo malignant transformation within the nail matrix. A symptom of the disease may be melanonychia, a streak of pigment or irregular discoloration, eventually it takes the form of a triangle. This symptom indicates an advanced stage of the disease. The basis for making the diagnosis is dermoscopy and biopsy. Grazzini et al. suggest conducting a biopsy in each case where one nail plate is affected and the lesion persists for more than 6 months. An important element of diagnostics that helps diagnose of subungual melanoma is the ABCDEF algorithm. Knowledge of the above-mentioned helps to detect disturbing symptoms at an early stage of the disease, which improves the prognosis and increases the chances of cure.
Summary:
Early detection of melanoma gives a better chance of cure, reduces mortality and complications of the disease, therefore any action to increase public knowledge and awareness on the subject is important.
References
Reilly D J, Aksakal G, Gilmour R F, Gyorki D E, Chauhan A, Webb A, Henderson A. Subungual melanoma: Management in the modern era. JPRAS. 2017; 70 (12): 17461752
Lee W J, Lee J H, Won C H, Chang S E, Choi J H, Moon K C, Lee M W. Nail apparatus melanoma: A comparative, clinicoprognostic study of the initial clinical and morphological characterictics of 49 patients. J Am Acad Dermatol 2015; 73 (2): 213-220 https://doi.org/10.1016/j.jaad.2015.04.044/
https://www.mp.pl/empendium (access 05.01.2024)
https://onkologia.org.pl (access 05.01.2024)
Singal A, Pandhi D, Gogoi P, Grover C. Subungual Melanoma is Not so Rare: Report of Four Cases from India. Indian. Dermatol. Online J. 2017; 8(6): 471–474.
Hałas P. Charakterystyka czerniaka oraz ocena poziomu wiedzy studentów na temat czerniaka złośliwego. Kosmetologia estetyczna. 2017; 3: 223-228
Jabłońska S, Majewski S, Czerniak złośliwy skóry[w:] Choroby skóry i choroby przenoszone drogą płciową. Red. H. Dubrowska. Wyd. PZWL. 2015; 15-22, 410-414
Kamińska-Winciorek G, Śpiewak R. Podstawy dermoskopii dla początkujących. Postępy Hig. Med. Dośw. 2011; 65: 501-508
Mole R J, MacKenzie D N. Subungual Melanoma. StatPearls Publishing. 2023
Leung A K C, Lam J M, Leong K F, Sergi C M. Melanonychia striata: clarifying behind the Black Curtain. A review on clinical evaluation and management of the 21st century. Int. J. Dermatol. 2019; 58: 1239–1245 https://doi.org/10.1111/ijd.14464
Jiyad Z, Akhras V. Incidence of melanoma and outcomes of longitudinal melanonychia in a cohort of cases referred to a London dermatology department. Br. J. Dermatol. 2019; 181(1): 204–205 https://doi.org/10.1111/bjd.17607
Catalán V, Yagnam M, Morales C, Villagra M. Is Hutchinson’s Sign Pathognomic of Subungual Melanoma? Actas Dermo-Sifiliográficas. 2017; 109 (6): 573-575
https://doi.org/10.1016/j.ad.2017.06.020
Levit E K, Kagen M H, Scher R K, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J. Am. Acad. Dermatol. 2000; 42: 269-274. doi:10.1016/S0190-9622(00)90137-3
Ko D, Oromendia C, Scher R, Lipner S R. Retrospective singlecenter study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019; 80(5) : 1272–1283 https://doi.org/10.1016/j.jaad.2018.08.033
Kamińska-Winciorek G, Śpiewak R. Diagnostyka dermoskopowa czerniaka podpaznokciowego. Postępy Hig. Med. Dośw. 2013; 67: 380-387
Alessandrini A, Starace M Piraccini B M. Dermoscopy in the Evaluation of Nail Disorders. Skin Appendage Disord. 2017; 3 (2): 70–82
Koga H, Saida T, Uhara H. Key point in dermoscopic differentiation between early nail apparatus melanoma and benign longitudinal melanonychia. J. Dermatol. 2011; 38: 45-52
Ohn J, Jo G, Cho Y, Sheu SL, Cho KH, Mun JH. Assessment of a Predictive Scoring Model for Dermoscopy of Subungual Melanoma In Situ. JAMA Dermatol. 2018; 154(8): 890-896
Flores-Terry M, Romero-Aguilera G, Mendoza C, Franco M, Cortina P, Garcia-Arpa M, Gonzalez-Ruiz L, Garrido J A. Functional Surgery for Malignant Subungual Tumors: A Case Series and Literature Review. Actas Dermo-Sifiliográficas .2018; 109(8): 712-721
Wollina U, Nenoff P, Haroske G, Haenssle HA. The Diagnosis and Treatment of Nail Disorders. Dtsch Arztebl Int. 2016;113(29-30): 509-18
Grazzini M, Rossari S, Gori A, Corciova S, Guerriero G, Lotti T, De Giorgi V. Subungueal pigmented lesions: warning for dermoscopic melanoma diagnosis. Eur. J. Dermatol. 2011; 21: 286-287
Jassem J, Krzakowski M.: Złośliwe nowotwory skóry. Praktyczny przewodnik dla lekarzy. Gdańsk 2011
Balch CM, Mihm MC, Gershenwald JE, Soong S. The Revised Melanoma Staging System and the Impact of Mitotic Rate. Fall. 2010; 28(3)
National Comprehensive Cancer Network Guidelines for Patients. Melanoma 2016.
Rutkowski P, Wysocki PJ, Nasierowska-Guttmejer A, Fijuth J, Kalinka-Warzocha E, i wsp. Cutaneous melanoma – diagnostic and therapeutic guidelines in 2016. Oncol Clin Pract. 2015; 11:216-31
Wszołek K. Czynniki ryzyka, klasyfikacja i leczenie czerniaka. Nauki przyrodnicze i medyczne: Postępy w farmakologii i onkologii. 2018; 33-50
Breslow A, Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma. Ann Surg. 1970 Nov; 172(5):902-8
Ebisz M, Brokowska M.: Szkodliwe oddziaływanie promieniowania ultrafioletowego na skórę człowieka. Hyg Pub Health. 2015; 50(3):467-73
Keung E Z, Gershenwald J E.The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Review of Anticancer Therapy. 2018 Jul; 18(8): 775-784
Ogata D, Namikawa K, Takahashi A,Yamazaki N. A review of the AJCC melanoma staging system in the TNM classification (eighth edition) . JJCO.2021 May; 51(5): 671-674
The drawings/figures were made independently.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anna Niemczyk, Magdalena Miłek, Monika Ślusarczyk, Weronika Stawska, Angelika Foryś, Ksenia Kwaśniak, Agata Magierska, Mariola Banach, Patrycja Bolla, Magdalena Staś
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 276
Number of citations: 0